López Fernández, M. J., Narejos, S., Castro, A., Echave Sustaeta, J. M., Forner, M. J., Arana Arri, E., . . . Natalini Martínez, S. (2024). Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.
Chicago Style CitationLópez Fernández, María Jesús, et al. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results. 2024.
MLA CitationLópez Fernández, María Jesús, et al. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results. 2024.
Warning: These citations may not always be 100% accurate.